Učitavanje...
Trastuzumab (Herceptin)
Herceptin (trastuzumab) is a human monoclonal antibody that interferes with the HER2 receptor. It is currently the only FDA-approved therapeutic antibody for HER2-positive breast cancer. This article will present the mechanism at action as well as the clinical role at this monoclonal antibody.
Spremljeno u:
| Izdano u: | AJNR Am J Neuroradiol |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society of Neuroradiology
2011
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7964332/ https://ncbi.nlm.nih.gov/pubmed/21816914 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3174/ajnr.A2619 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|